← Eichor
Study identifier: NCT05752383 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care

Condition: Cardiogenic Shock  ·  Sponsor: Centre Hospitalier Universitaire, Amiens

PhaseN/A
Planned participants500
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Cardiogenic shock is a frequent reason for hospitalization in critical care units, with high mortality (50%). Several French registries have been created to improve knowledge of the prognostic factors of cardiogenic shock. In recent years, temporary mechanical circulatory support has become more important in cardiogenic shock. The monitoring of catecholamines is also performed with a global score: the vaso-inotropic score. The purpose of our study is to consider using these new data and techniques to create a cohort of cardiogenic shock within our critical care unit. This observational study is based on clinical, biological, and hemodynamic data recorded during the ICU stay of patients for cardiogenic shock. The primary endpoint is the relationship between the hemodynamic evolution of cardiogenic shock and in-hospital mortality.

This description comes directly from the study's public registry record.

Talk to the study team

Christophe Beyls, MD  ·  03 22 08 78 66  ·  beyls.christophe@chu-amiens.fr

Always discuss trial participation with your own doctor first.

Locations (1)

CHU Amiens PicardieAmiens, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05752383